Similarly, cytarabine was found to increase the expression of co-stimulatory molecules by AML cells whilst decreasing the expression of PD-L1, making them more susceptible to cytotoxic lymphocyte-mediated killing [36]. Here, CD274 is linked to acute myeloid leukemia.